Zymeworks ZYME
NASDAQ ZYME
$29.40 -0.50 (-1.66%)
As of: Sep 4, 2026 · 3:15 PM EDT

Zymeworks (ZYME) Deferred Taxes (2021 - 2026)

Zymeworks (ZYME) posted Deferred Taxes of $2.2 million for Q1 2026, up 256.03% sequentially from -$1.4 million in Q4 2025, and up 436.59% YoY from $410000.0 in Q1 2025.

Analysis

Zymeworks (ZYME) Deferred Taxes (2021 - 2026) Analysis & Trends

Zymeworks has reported Deferred Taxes for 6 years, with the latest figure at $2.2 million in Q1 2026.

  • Quarterly Deferred Taxes rose 436.59% year-over-year to $2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $845000.0 (up 364.89% YoY) and the FY2025 annual result came in at -$945000.0, down 36.76% from the prior year.
  • Deferred Taxes grew to $2.2 million in Q1 2026 per ZYME's latest filing, from -$1.4 million in the prior quarter.
  • Over five years, Deferred Taxes peaked at $2.2 million in Q1 2026 and troughed at -$1.9 million in Q4 2022.
  • A 5-year average of -$36411.8 and a median of $38000.0 in 2024 frame the typical range for Deferred Taxes.
  • The sharpest annual moves came in 2022 and 2025: Deferred Taxes tumbled 249.76% in 2022, then surged 978.95% in 2025.
  • Over 5 years, Deferred Taxes stood at -$1.9 million in 2022, then surged by 151.41% to $967000.0 in 2023, then tumbled by 216.55% to -$1.1 million in 2024, then retreated by 25.11% to -$1.4 million in 2025, then jumped by 256.03% to $2.2 million in 2026.
  • According to Business Quant data, Deferred Taxes over the past three periods registered $2.2 million, -$1.4 million, and $170000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn -69.70 Mn
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn 194.40 Mn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn -
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn -
5 Revolution Medicines 44.02 Bn 44.02 Bn - -
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn 2.66 Mn
8 Royalty Pharma 28.43 Bn 27.59 Bn - -
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
10 Zymeworks 2.15 Bn 1.88 Bn - -265,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -265,000.00
Mar 31, 2026 2.20 Mn
Dec 31, 2025 -1.41 Mn
Sep 30, 2025 170,000.00
Jun 30, 2025 -115,000.00
Mar 31, 2025 410,000.00
Dec 31, 2024 -1.13 Mn
Sep 30, 2024 204,000.00
Jun 30, 2024 194,000.00
Mar 31, 2024 38,000.00
Dec 31, 2023 967,000.00
Sep 30, 2023 -95,000.00
Jun 30, 2023 -106,000.00
Mar 31, 2023 -9,000.00
Dec 31, 2022 -1.88 Mn
Sep 30, 2022 411,000.00
Jun 30, 2022 265,000.00
Mar 31, 2022 -735,000.00
Dec 31, 2021 1.26 Mn